Search results
Results From The WOW.Com Content Network
Pfizer expects 2024 operational revenue growth of 9%- 11% year over year, up from 8%- 10% provided on January 30, 2024. ... Price Action: PFE stock is up 1.60% at $31.21 during the premarket ...
Pfizer disappointed Wall Street this week with lower revenue guidance for the upcoming year, giving analysts another reason to doubt the company and its stock.Shares for Pfizer were at the end of ...
The $771 million adjustment to the estimated revenue reversal of $3.5 billion last quarter reflects 1.4 million fewer treatment courses returned by the U.S. government through Feb. 29, 2024 versus ...
S&P 500 Dividend Aristocrats. The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005.
American Cyanamid Company was an American manufacturing conglomerate. It began as a fertilizer company and added many additional lines of business before merging with American Home Products in 1994. The combined company sold off most of its divisions, adopted the name of its remaining Wyeth division, and was bought by Pfizer in 2009, becoming ...
A potential buyer bids a specific price for a stock, and a potential seller asks a specific price for the same stock. Buying or selling at the Market means you will accept any ask price or bid price for the stock. When the bid and ask prices match, a sale takes place, on a first-come, first-served basis if there are multiple bidders at a given ...
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID ...